BR112023000142A2 - Derivados de benzodiazepina úteis no tratamento de infecção pelo vírus sincicial respiratório - Google Patents
Derivados de benzodiazepina úteis no tratamento de infecção pelo vírus sincicial respiratórioInfo
- Publication number
- BR112023000142A2 BR112023000142A2 BR112023000142A BR112023000142A BR112023000142A2 BR 112023000142 A2 BR112023000142 A2 BR 112023000142A2 BR 112023000142 A BR112023000142 A BR 112023000142A BR 112023000142 A BR112023000142 A BR 112023000142A BR 112023000142 A2 BR112023000142 A2 BR 112023000142A2
- Authority
- BR
- Brazil
- Prior art keywords
- respiratory syncytial
- syncytial virus
- treatment
- derivatives useful
- virus infection
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Abstract
DERIVADOS DE BENZODIAZEPINA ÚTEIS NOTRATAMENTO DE INFECÇÃO PELO VÍRUS SINCICIAL RESPIRATÓRIO. São descritos compostos derivados de benzodiazepina e sais farmaceuticamente aceitáveis dos mesmos, além de composições e produtos compreendendo os mesmos, e seus usos no tratamento ou prevenção de uma infecção pelo vírus sincicial respiratório (VSR).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2010409.7A GB202010409D0 (en) | 2020-07-07 | 2020-07-07 | Pharmaceutical compounds |
PCT/GB2021/051731 WO2022008911A1 (en) | 2020-07-07 | 2021-07-07 | Benzodiazepine derivatives useful in treating a respiratory syncytial virus infection |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112023000142A2 true BR112023000142A2 (pt) | 2023-01-31 |
Family
ID=72050502
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112023000142A BR112023000142A2 (pt) | 2020-07-07 | 2021-07-07 | Derivados de benzodiazepina úteis no tratamento de infecção pelo vírus sincicial respiratório |
Country Status (10)
Country | Link |
---|---|
US (1) | US20230270751A1 (pt) |
EP (1) | EP4178964A1 (pt) |
JP (1) | JP2023539985A (pt) |
KR (1) | KR20230035597A (pt) |
CN (1) | CN116075516A (pt) |
BR (1) | BR112023000142A2 (pt) |
CA (1) | CA3188752A1 (pt) |
GB (1) | GB202010409D0 (pt) |
MX (1) | MX2023000440A (pt) |
WO (1) | WO2022008911A1 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201911944D0 (en) | 2019-08-20 | 2019-10-02 | Reviral Ltd | Pharmaceutical compounds |
GB202102602D0 (en) | 2021-02-24 | 2021-04-07 | Reviral Ltd | Pharmaceutical compounds |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101125899B1 (ko) | 2002-09-20 | 2012-04-12 | 애로우 쎄라퓨틱스 리미티드 | 벤조디아제핀 유도체 및 이를 함유하는 약학 조성물 |
US20070293482A1 (en) | 2004-03-19 | 2007-12-20 | Novartis Pharmaceuticals Corporation | Process for Preparing Benzodiazepines |
GB0406280D0 (en) | 2004-03-19 | 2004-04-21 | Arrow Therapeutics Ltd | Chemical compounds |
GB201506448D0 (en) | 2015-04-16 | 2015-06-03 | Univ Durham | An antimicrobial compound |
RU2738232C2 (ru) | 2015-07-22 | 2020-12-09 | Энанта Фармасьютикалс, Инк. | Производные бензодиазепина как ингибиторы rsv |
GB201613942D0 (en) | 2016-08-15 | 2016-09-28 | Univ Of Durham The | An antimicrobial compound |
WO2018129287A1 (en) | 2017-01-06 | 2018-07-12 | Enanta Pharmaceuticals, Inc. | Heteroaryldiazepine derivatives as rsv inhibitors |
US10752598B2 (en) | 2017-06-07 | 2020-08-25 | Enanta Pharmaceuticals, Inc. | Aryldiazepine derivatives as RSV inhibitors |
GB201911944D0 (en) | 2019-08-20 | 2019-10-02 | Reviral Ltd | Pharmaceutical compounds |
-
2020
- 2020-07-07 GB GBGB2010409.7A patent/GB202010409D0/en not_active Ceased
-
2021
- 2021-07-07 BR BR112023000142A patent/BR112023000142A2/pt unknown
- 2021-07-07 JP JP2023501029A patent/JP2023539985A/ja active Pending
- 2021-07-07 KR KR1020237003865A patent/KR20230035597A/ko unknown
- 2021-07-07 CA CA3188752A patent/CA3188752A1/en active Pending
- 2021-07-07 MX MX2023000440A patent/MX2023000440A/es unknown
- 2021-07-07 US US18/004,504 patent/US20230270751A1/en active Pending
- 2021-07-07 CN CN202180053511.8A patent/CN116075516A/zh active Pending
- 2021-07-07 EP EP21746095.5A patent/EP4178964A1/en active Pending
- 2021-07-07 WO PCT/GB2021/051731 patent/WO2022008911A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US20230270751A1 (en) | 2023-08-31 |
GB202010409D0 (en) | 2020-08-19 |
KR20230035597A (ko) | 2023-03-14 |
CA3188752A1 (en) | 2022-01-13 |
WO2022008911A1 (en) | 2022-01-13 |
EP4178964A1 (en) | 2023-05-17 |
CN116075516A (zh) | 2023-05-05 |
JP2023539985A (ja) | 2023-09-21 |
MX2023000440A (es) | 2023-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO2020026I1 (no) | Raltegravir eller et farmasøytisk akseptabelt salt derav, spesielt kaliumsaltet | |
ZA202107015B (en) | Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use | |
BRPI0414330A (pt) | composto, processo para preparação do mesmo, métodos para produção de um efeito antibacteriano, para inibição de dna girase bacteriana, e para tratamento de uma infecção bacteriana em um animal de sangue quente, uso de um composto, e, composição farmacêutica | |
BR112023000142A2 (pt) | Derivados de benzodiazepina úteis no tratamento de infecção pelo vírus sincicial respiratório | |
BR0208811A (pt) | Derivados de pirazol para tratamento de hiv | |
ATE355064T1 (de) | Dihydroxypyrimidin-carbonsäueramid-hemmer der hiv-integrase | |
ES2051641B1 (es) | Procedimientos para la preparacion de compuestos derivados de tiourea. | |
TR200500745T2 (tr) | Damar gelişimi inhibitörleri olarak kuinazolin türevleri. | |
EA202190854A1 (ru) | Ингибиторы репликации вируса иммунодефицита человека | |
BR112021025655A2 (pt) | Inibidores da replicação do vírus da imunodeficiência humana | |
PH12021550632A1 (en) | Monomer and multimeric anti-hbv agents | |
WO2015160907A3 (en) | Potent and selective inhibitors of hepatitis c virus | |
BR9912142A (pt) | 6-benzil-4-oxipirimidinas substituìdas, processopara sua preparação e composições contendo-as | |
EA202092439A1 (ru) | Гетероароматические соединения, обладающие активностью против rsv | |
MX2022009871A (es) | Compuestos tetraciclicos para tratar la infeccion por el virus de la inmunodeficiencia humana (vih). | |
EA202193223A1 (ru) | Другие гетероароматические соединения, действующие против рсв | |
EA202191482A1 (ru) | Другие гетероароматические соединения, обладающие активностью против rsv | |
EA202091835A1 (ru) | Замещенные циклоалкилом пиразолопиримидины, обладающие активностью против rsv | |
MX2023008137A (es) | Compuestos de piridotriazina sustituidos y usos de estos. | |
ATE554764T1 (de) | Wirkungsvolle vereinfachte derivate von immunosuppressiva | |
EA202290157A1 (ru) | Производные третичных аминов и их применение для лечения вирусной инфекции | |
NO965591L (no) | Kombinasjonsbehandling av HIV-infeksjon | |
BR112018002681A2 (pt) | ?composto, composição, e, método para tratamento de infecção por hiv? | |
EA202192268A1 (ru) | Мостиковые трициклические карбамоилпиридоновые соединения и их фармацевтическое применение | |
ES2190456T3 (es) | Combinacion de inhibidores de la proteasa del vih. |